Yuyang Tian
No.1163 Xinmin Street
Changchun, 130021, China
Changchun, 130021, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications
Daratumumab-based first-line therapy benefit multiple myeloma patients in a real-world setting: a multi-center retrospective propensity score-match study.
Journal: Annals of hematology
Published: September 09, 2025
Impact of SARS-CoV-2 infection on clinical characteristics, antibody levels, and immune responses in patients with malignant hematological tumors.
Journal: Journal of chemotherapy (Florence, Italy)
Published: February 14, 2025
Narcolepsy and psychiatric disorders: A bidirectional Mendelian randomization study.
Journal: Journal of psychiatric research
Published: July 27, 2023
Expert consensus on microtransplant for acute myeloid leukemia in elderly patients -report from the international microtransplant interest group.
Journal: Heliyon
Published: January 27, 2023
MiR-140 targets lncRNA FAM230B to suppress cell proliferation in acute myeloid leukemia running title: MiR-140 targets FAM230B in AML.
Journal: Hematology (Amsterdam, Netherlands)
Published: June 06, 2022
Rituximab plus cladribine versus R-CHOP in frontline management of marginal zone lymphoma in China: a propensity-score matched multicenter study.
Journal: Annals of hematology
Published: March 10, 2022
Ibrutinib as monotherapy versus combination therapy in Chinese patients with relapsed/refractory mantle cell lymphoma: A multicenter study.
Journal: Cancer medicine
Published: September 02, 2021
Association between miR-212-3p and SOX11, and the effects of miR-212-3p on cell proliferation and migration in mantle cell lymphoma.
Journal: Oncology letters
Published: July 23, 2020
Lentivirus-mediated down-regulation of CK2α inhibits proliferation and induces apoptosis of malignant lymphoma and leukemia cells.
Journal: Biochemistry and cell biology = Biochimie et biologie cellulaire
Published: May 18, 2018
Significance of the microRNA‑17‑92 gene cluster expressed in B‑cell non‑Hodgkin's lymphoma.
Journal: Molecular medicine reports
Published: October 31, 2017
The FCGR3A polymorphism predicts the response to rituximab-based therapy in patients with non-Hodgkin lymphoma: a meta-analysis.
Journal: Annals of hematology
Published: December 20, 2015
Showing 1-12 of 12
Last Updated: 09/26/2026